Orexin-A is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Orexin-A is administered via intranasal (experimental human), intracerebroventricular (animal studies) at not established for human peptide administration single dose in research protocols. Subcutaneous injections into the abdominal fat or thigh are most common. Proper reconstitution with bacteriostatic water is required first.
How Do You Inject Orexin-A?
Orexin-A is administered via intranasal (experimental human), intracerebroventricular (animal studies). For most researchers, subcutaneous injection is the standard approach — it's simple, relatively painless, and effective for Neuropeptide hormone compounds.
This guide covers injection technique, site selection, needle choices, and common mistakes.
How Do You Prepare for a Orexin-A Injection?
Step 1: Wash your hands thoroughly.
Step 2: Clean the top of the Orexin-A vial and BAC water vial with alcohol swabs. If not yet reconstituted, see our Orexin-A reconstitution guide.
Step 3: Draw your dose (not established for human peptide administration) into an insulin syringe. Use our calculator for exact units.
Step 4: Clean the injection site with an alcohol swab and let it dry.
What Is the Correct Injection Technique?
Subcutaneous (most common): Pinch a fold of skin — typically abdominal fat 2+ inches from the navel, or the thigh. Insert the needle at a 45-degree angle. Push the plunger slowly and steadily. Hold for 5 seconds, then withdraw.
Intramuscular (less common for Orexin-A): Insert the needle at 90 degrees into the muscle (deltoid or vastus lateralis). This route provides faster absorption but isn't necessary for most peptide protocols.
Rotate injection sites to prevent lipodystrophy (fat tissue changes from repeated injections in the same spot).
What Size Needle Should You Use?
For subcutaneous Orexin-A injections, 29-31 gauge insulin needles (½ inch or 8mm) are standard. These are thin enough to be nearly painless while long enough for proper subcutaneous delivery.
Use a fresh needle for every injection. Never reuse or share needles.
Calculate Your Orexin-A Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Orexin-A.
Open Calculator →What Are Common Injection Side Effects?
Mild redness, swelling, or itching at the injection site is normal and typically resolves within hours. Small bruises can occur, especially if you hit a capillary.
If you experience persistent pain, swelling, warmth, or redness lasting more than 24 hours, discontinue and consult a healthcare provider — these may indicate infection.
Bottom Line on Orexin-A Injection
Orexin-A is administered via intranasal (experimental human), intracerebroventricular (animal studies) at not established for human peptide administration single dose in research protocols. Subcutaneous injection with a 29-31 gauge insulin needle into abdominal fat is the standard technique. Rotate sites and use a fresh needle every time.
Complete Guide
Orexin-A : Benefits, Dosage, Side Effects & Research
Related Reading
- Orexin-A Dosage Guide
- Orexin-A Benefits
- Orexin-A Side Effects
- Orexin-A Stacking Guide
- Orexin-A Cycle Guide
- Orexin-A Research
Research-Grade Sourcing
If you're going to research Orexin-A, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Orexin-A?
Orexin-A (Hypocretin-1) is a Neuropeptide hormone. Naturally occurring peptide synthesized in the hypothalamus, regulating sleep-wake cycles and arousal. It is researched for increased wakefulness and arousal, cognitive function in narcolepsy, pain modulation.
What is the recommended Orexin-A dosage?
Common dosages: not established for human peptide administration administered single dose in research protocols via intranasal (experimental human), intracerebroventricular (animal studies). Cycle length: single dose protocols; no established multi-week cycles. Half-life: rapidly degraded peripherally; central CSF half-life estimated 10-30 minutes. Use our peptide calculator for exact reconstitution math.
What are the side effects of Orexin-A?
Limited human safety data. Potential increased heart rate and blood pressure. Poor blood-brain-barrier penetration limits peripheral dosing.
Is Orexin-A safe?
Orexin-A has shown a preliminary safety profile in research. Not FDA-approved. Research use only. Development focus has shifted to small molecule receptor agonists. All research should follow appropriate safety protocols.